journal article
Open Access
Mar 16, 2010
Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration
Abstract
Abstract
Introduction
Infections produce severe respiratory muscle weakness, which contributes to the development of respiratory failure. An effective, safe therapy to prevent respiratory muscle dysfunction in infected patients has not been defined. This study examined the effect of eicosapentaenoic acid (EPA), an immunomodulator that can be safely administered to patients, on diaphragm force generation following endotoxin administration.
Methods
Rats were administered the following (n = 5/group): (a) saline, (b) endotoxin, 12 mg/kg IP, (c) endotoxin + EPA (1.0 g/kg/d), and (d) EPA alone. Diaphragms were removed and measurements made of the diaphragm force-frequency curve, calpain activation, caspase activation, and protein carbonyl levels.
Results
Endotoxin elicited large reductions in diaphragm specific force generation (P < 0.001), and increased diaphragm caspase activation (P < 0.01), calpain activation (P < 0.001) and protein carbonyl levels (P < 0.01). EPA administration attenuated endotoxin-induced reductions in diaphragm specific force, with maximum specific force levels of 27 ± 1, 14 ± 1, 23 ± 1, and 24 ± 1 N/cm2, respectively, for control, endotoxin, endotoxin + EPA, and EPA treated groups (P < 0.001). EPA did not prevent endotoxin induced caspase activation or protein carbonyl formation but significantly reduced calpain activation (P < 0.02).
Conclusions
These data indicate that endotoxin-induced reductions in diaphragm specific force generation can be partially prevented by administration of EPA, a nontoxic biopharmaceutical that can be safely given to patients. We speculate that it may be possible to reduce infection-induced skeletal muscle weakness in critically ill patients by administration of EPA.
Introduction
Infections produce severe respiratory muscle weakness, which contributes to the development of respiratory failure. An effective, safe therapy to prevent respiratory muscle dysfunction in infected patients has not been defined. This study examined the effect of eicosapentaenoic acid (EPA), an immunomodulator that can be safely administered to patients, on diaphragm force generation following endotoxin administration.
Methods
Rats were administered the following (n = 5/group): (a) saline, (b) endotoxin, 12 mg/kg IP, (c) endotoxin + EPA (1.0 g/kg/d), and (d) EPA alone. Diaphragms were removed and measurements made of the diaphragm force-frequency curve, calpain activation, caspase activation, and protein carbonyl levels.
Results
Endotoxin elicited large reductions in diaphragm specific force generation (P < 0.001), and increased diaphragm caspase activation (P < 0.01), calpain activation (P < 0.001) and protein carbonyl levels (P < 0.01). EPA administration attenuated endotoxin-induced reductions in diaphragm specific force, with maximum specific force levels of 27 ± 1, 14 ± 1, 23 ± 1, and 24 ± 1 N/cm2, respectively, for control, endotoxin, endotoxin + EPA, and EPA treated groups (P < 0.001). EPA did not prevent endotoxin induced caspase activation or protein carbonyl formation but significantly reduced calpain activation (P < 0.02).
Conclusions
These data indicate that endotoxin-induced reductions in diaphragm specific force generation can be partially prevented by administration of EPA, a nontoxic biopharmaceutical that can be safely given to patients. We speculate that it may be possible to reduce infection-induced skeletal muscle weakness in critically ill patients by administration of EPA.
Topics
No keywords indexed for this article. Browse by subject →
References
44
[1]
Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, Zedda C, Billiar T, Payen D, Aubier M, Boczkowski J: Muscular contractile failure in septic patients: role of the inducible nitric oxide synthase pathway.
Am J Respir Crit Care Med 2000, 162: 2308-2315.
10.1164/ajrccm.162.6.2001097
[2]
Poponick J, Jacobs I, Supinski G, DiMarco A: Effects of upper respiratory tract infections on respiratory muscle strength in patients with neuromuscular disease.
Am J Respir Crit Care Med 1997, 156: 659-664.
10.1164/ajrccm.156.2.9611029
[3]
Shindoh C, Hida W, Ohkawara Y, Yamauchi K, Ohno I, Takishima T, Shirato K: TNF-alpha mRNA expression in diaphragm muscle after endotoxin administration.
Am J Respir Crit Care Med 1995, 152: 1690-1696.
10.1164/ajrccm.152.5.7582314
[4]
Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, Aspiotis R, Han Y, Nicholson DW, Karl IE: Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.
Nat Immunol 2000, 1: 496-501. 10.1038/82741
10.1038/82741
[5]
Supinski GS, Callahan LA: Free radical-mediated skeletal muscle dysfunction in inflammatory conditions.
J Appl Physiol 2007, 102: 2056-2063. 10.1152/japplphysiol.01138.2006
10.1152/japplphysiol.01138.2006
[6]
Nethery D, DiMarco A, Stofan D, Supinski G: Sepsis increases contraction-related generation of reactive oxygen species in the diaphragm.
J Appl Physiol 1999, 87: 1279-1286.
10.1152/jappl.1999.87.4.1279
[7]
Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO: Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.
Am J Physiol Regul Integr Comp Physiol 2006, 290: R1589-R1597.
10.1152/ajpregu.00668.2005
[8]
Du J, Wang X, Miereles C, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE: Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.
J Clin Invest 2004, 113: 115-123.
10.1172/jci18330
[9]
Zhang Z, Biesiadecki BJ, Jin JP: Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage.
Biochemistry 2006, 45: 11681-11694. 10.1021/bi060273s
10.1021/bi060273s
[10]
Callahan LA, She ZW, Nosek TM: Superoxide, hydroxyl radical, and hydrogen peroxide effects on single-diaphragm fiber contractile apparatus.
J Appl Physiol 2001, 90: 45-54.
10.1152/jappl.2001.90.1.45
[11]
Lynch AM, Moore M, Craig S, Lonergan PE, Martin DS, Lynch MA: Analysis of interleukin-1 beta-induced cell signaling activation in rat hippocampus following exposure to gamma irradiation. Protective effect of eicosapentaenoic acid.
J Biol Chem 2003, 278: 51075-51084. 10.1074/jbc.M307970200
10.1074/jbc.m307970200
[12]
Saito M, Kubo K: Relationship between tissue lipid peroxidation and peroxidizability index after alpha-linolenic, eicosapentaenoic, or docosahexaenoic acid intake in rats.
Br J Nutr 2003, 89: 19-28. 10.1079/BJN2002731
10.1079/bjn2002731
[13]
Tisdale MJ: The 'cancer cachectic factor'.
Support Care Cancer 2003, 11: 73-78.
10.1007/s00520-002-0408-6
[14]
Khal J, Tisdale MJ: Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
Biochem Biophys Res Commun 2008, 375: 238-240. 10.1016/j.bbrc.2008.08.004
10.1016/j.bbrc.2008.08.004
[15]
Bloomer RJ, Larson DE, Fisher-Wellman KH, Galpin AJ, Schilling BK: Effect of eicosapentaenoic and docosahexaenoic acid on resting and exercise-induced inflammatory and oxidative stress biomarkers: a randomized, placebo controlled, cross-over study.
Lipids Health Dis 2009, 8: 36-40. 10.1186/1476-511X-8-36
10.1186/1476-511x-8-36
[16]
Yokoyama M, Origasa H, JELIS Investigators: Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
Am Heart J 2003, 146: 613-620. 10.1016/S0002-8703(03)00367-3
10.1016/s0002-8703(03)00367-3
[17]
Whitehouse AS, Tisdale MJ: Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Biochem Biophys Res Commun 2001, 285: 598-602. 10.1006/bbrc.2001.5209
10.1006/bbrc.2001.5209
[18]
Nasa Y, Hyashi M, Sasaki H, Hayashi J, Takeo S: Long-term supplementation with eicosapentaenoic acid salvages cardiomyocytes from hypoxia/reoxygenation-induced injury in rats fed with fish-oil-deprived diet.
Jpn J Pharmacol 1998, 77: 137-146. 10.1254/jjp.77.137
10.1254/jjp.77.137
[19]
Supinski GS, Callahan LA: Caspase activation contributes to endotoxin-induced diaphragm weakness.
J Appl Physiol 2006, 100: 1770-1777. 10.1152/japplphysiol.01288.2005
10.1152/japplphysiol.01288.2005
[20]
Supinski GS, Vanags J, Callahan LA: Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
Am J Physiol Lung Cell Mol Physiol 2009, 296: L994-L1001. 10.1152/ajplung.90404.2008
10.1152/ajplung.90404.2008
[21]
Supinski G, Nethery D, Stofan D, DiMarco A: Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles.
J Appl Physiol 1996, 81: 1370-1378.
10.1152/jappl.1996.81.3.1370
[22]
Close RI: The dynamic properties of mammalian skeletal muscles.
Physiol Rev 1972, 52: 129-197.
10.1152/physrev.1972.52.1.129
[23]
Laghi F, Cattapan SE, Jubran A, Parthasarathy S, Warshawsky P, Choi YS, Tobin MJ: Is weaning failure caused by low-frequency fatigue of the diaphragm?
Am J Respir Crit Care Med 2003, 167: 120-127. 10.1164/rccm.200210-1246OC
10.1164/rccm.200210-1246oc
[24]
Measurement of twitch transdiaphragmatic, esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic nerve stimulation in patients in the intensive care unit
Anna C. Watson, PHILIP D. HUGHES, M. Louise Harris et al.
Critical Care Medicine
2001
10.1097/00003246-200107000-00005
[25]
Laghi F, Tobin MJ: Disorders of the respiratory muscles.
Am J Respir Crit Care Med 2003, 168: 10-48. 10.1164/rccm.2206020
10.1164/rccm.2206020
[26]
Maes K, Testelmans D, Powers S, Decramer M, Gayan-Ramirez G: Leupeptin inhibits ventilator-induced diaphragm dysfunction in rats.
Am J Respir Crit Care Med 2007, 175: 1134-1138. 10.1164/rccm.200609-1342OC
10.1164/rccm.200609-1342oc
[27]
Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ: Insulin therapy protects the central and peripheral nervous system of intensive care patients.
Neurology 2005, 64: 1348-1353.
10.1212/01.wnl.0000158442.08857.fc
[28]
Supinski G, Nethery D, Nosek TM, Callahan LA, Stofan D, DiMarco A: Endotoxin administration alters the force vs.pCa relationship of skeletal muscle fibers.
Am J Physiol Regul Integr Comp Physiol 2000, 278: R891-R896.
10.1152/ajpregu.2000.278.4.r891
[29]
Divangahi M, Matecki S, Dudley RW, Tuck SA, Bao W, Radzioch D, Comtois AS, Petrof BJ: Preferential diaphragmatic weakness during sustained Pseudomonas aeruginosa lung infection.
Am J Respir Crit Care Med 2004, 169: 679-686. 10.1164/rccm.200307-949OC
10.1164/rccm.200307-949oc
[30]
Fujimura N, Sumita S, Aimono M, Masuda Y, Schichinohe Y, Narimatsu E, Namiki A: Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis.
Am J Respir Crit Care Med 2000, 162: 2159-2165.
10.1164/ajrccm.162.6.9912144
[31]
Drew JS, Farkas GA, Pearson RD, Rochester DF: Effects of a chronic wasting infection on skeletal muscle size and contractile properties.
J Appl Physiol 1988, 64: 460-465.
10.1152/jappl.1988.64.1.460
[32]
Callahan LA, Nethery D, Stofan D, DiMarco A, Supinski GS: Free radical-induced contractile protein dysfunction in endotoxin-induced sepsis.
Am J Respir Cell Mol Biol 2001, 24: 210-217.
10.1165/ajrcmb.24.2.4075
[33]
Callahan LA, Stofan D, Szweda L, Nethery D, Supinski GS: Free radicals alter maximal diaphragmatic oxygen consumption in endotoxin-induced sepsis.
Free Rad Biol Med 2001, 30: 129-138. 10.1016/S0891-5849(00)00454-8
10.1016/s0891-5849(00)00454-8
[34]
Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat medel of sepsis.
Am J Respir Crit Care Med 2001, 163: 218-225.
10.1164/ajrccm.163.1.2003109
[35]
Hasselgren PO: Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
Mol Biol Rep 1999, 26: 71-76. 10.1023/A:1006916206260
10.1023/a:1006916206260
[36]
Goll DE, Neti G, Mares SW, Thompson VF: Myofibrillar protein turnover: the proteasome and the calpains.
J Anim Sci 2008, 86: E19-E35. 10.2527/jas.2007-0395
10.2527/jas.2007-0395
[37]
Powers SK, Kavazis AN, DeRuisseau KC: Mechanisms of disuse muscle atrophy: role of oxidative stress.
Am J Physiol Regul Integr Comp Physiol 2005, 288: R337-R344.
10.1152/ajpregu.00469.2004
[38]
Friedrich P: The intriguing Ca2+ requirement of calpain activation.
Biochem Biophys Res Commun 2004, 323: 1131-1133. 10.1016/j.bbrc.2004.08.194
10.1016/j.bbrc.2004.08.194
[39]
Supinski GS, Ji X, Wang W, Callahan LA: The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction.
J Appl Physiol 2007, 102: 1649-1657. 10.1152/japplphysiol.00377.2006
10.1152/japplphysiol.00377.2006
[40]
Fischer DR, Sun X, Williams AB, Gang G, Pritts TA, James JH, Molloy M, Fischer JE, Paul RJ, Hasselgren PO: Dantrolene reduces serum TNFalpha and corticosterone levels and muscle calcium, calpain gene expression, and protein breakdown in septic rats.
Shock 2001, 15: 200-207. 10.1097/00024382-200115030-00007
10.1097/00024382-200115030-00007
[41]
Honen BN, Saint DA, Laver DR: Suppression of calcium sparks in rat ventricular myocytes and direct inhibition of sheep cardiac RyR channels by EPA, DHA and oleic acid.
J Membr Biol 2003, 196: 95-103. 10.1007/s00232-003-0628-9
10.1007/s00232-003-0628-9
[42]
Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A: Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation.
Mol Cell Biol 2004, 24: 2499-2512. 10.1128/MCB.24.6.2499-2512.2004
10.1128/mcb.24.6.2499-2512.2004
[43]
Wei W, Fareed MU, Evenson A, Menconi MJ, Yang H, Petkova V, Hasselgren PO: Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3.
Am J Physiol Regul Integr Comp Physiol 2005, 288: R580-R590.
10.1152/ajpregu.00341.2004
[44]
Furukawa K: Soybean oil, stress response, and immune function: a clinical study.
Nutrition 2003, 19: 212-216. 10.1016/S0899-9007(02)01066-3
10.1016/s0899-9007(02)01066-3
Metrics
33
Citations
44
References
Details
- Published
- Mar 16, 2010
- Vol/Issue
- 14(2)
- License
- View
Cite This Article
Gerald S Supinski, Jonas Vanags, Leigh Ann Callahan (2010). Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration. Critical Care, 14(2). https://doi.org/10.1186/cc8913
Related
You May Also Like
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
John A Kellum, Norbert Lameire · 2013
2,257 citations
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
Donat R. Spahn, Bertil Bouillon · 2019
1,054 citations
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Wentao Ni, Xiuwen Yang · 2020
907 citations
Burn wound healing and treatment: review and advancements
Matthew P. Rowan, Leopoldo C. Cancio · 2015
777 citations